We are monitoring the impact of COVID-19 on Asia Pacific Cardiac Marker Testing Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4806
Share on
Share on

Asia Pacific Cardiac Marker Testing Market Research Report – Segmented By Type, Product, Disease, Testing & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2019 - 2024)

Pulished: February, 2020
ID: 4806
Pages: 145

Asia Pacific Cardiac Marker Testing Market Size & Growth (2019 – 2024):

The Size of the Asia Pacific Cardiac Marker Testing Market is expected to grow at 11.7% CAGR from 2019 to 2024 and it is projected that the market is valued at USD 0.44 billion in 2019 and is anticipated to reach USD 0.76 billion by 2024.

Factor such as an increase in the incidence and occurrences of cardiovascular diseases is among the main factors driving the market growth.  Furthermore, a number of factors such as growing instances of cardiovascular diseases, the rapidly increasing geriatric population, growing to fund from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the cardiac marker testing market. On the other hand, technical problems related to sample collection and storage and issues related to regulatory and reimburse schemes are expected to hinder the growth of the market.

In addition to this, public-private initiatives to increase awareness related to early cardiac disease diagnosis in patients and physicians and increasing knowledge about technological advancements among lab professionals and cardiologists due to ongoing conferences and seminars are the key factors propelling the demand for cardiac biomarkers in the emerging markets.

The Asia-pacific market is expected to register the highest growth. Emerging markets, including India and China, have become attractive destinations for companies engaged in the development and marketing of cardiac biomarkers. Rising prevalence and incidence of cardiovascular diseases are among the major driving factors for the growth of this market in China and India.

For instance, annual cardiovascular events in China were projected to increase by more than 50% from 2010 to 2030. China has one of the highest CVD death rates in the world and it is estimated that one in 5 adults in China has cardiovascular disease.

Asia Pacific Cardiac Marker Testing Market has been segmented and sub-segmented into the following categories 

  • By Type: Troponin I & T, CK-MB, Myoglobin, BNP, hs-CRP
  • By Product: Reagent, Instrument (Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA))
  • By Disease: Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure
  • By Testing Lab, POC.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC.

Top Companies leading the Asia Pacific Cardiac Marker Testing Market Profiled in the report are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS Roche Diagnostics Ltd., Abbott Laboratories, Siemens AG, Danaher Corporation, Alere Inc., bioMérieux SA, LSI Medience Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd, and Guangzhou Wondfo Biotech Co. Ltd.

1.Introduction         

                1.1 Market Definition   

                1.2 Study Deliverables 

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions 

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases     

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary 

                3.2 Key Inferences

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints   

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Product       

                                5.1.1 Introduction                                           

                                5.1.2 Reagents and Kits                                

                                5.1.3 Instruments                                           

5.1.3.1 Chemiluminescence                        

5.1.3.2 Immunofluorescence                     

5.1.3.3 Elisa                        

5.1.3.4 Immunochromatography                              

                                5.1.4  Y-o-Y Growth Analysis, By Product                                              

                                5.1.5  Market Attractiveness Analysis, By Product                                            

                                5.1.6  Market Share Analysis, By Product                                              

                5.2 Type     

                                5.2.1 Introduction                                           

                                5.2.2 Troponin I & T                                        

                                5.2.3 CK-MB                                      

                                5.2.4 Myoglobin

                                5.2.5 BNP                                            

                                5.2.6 hsCRP                                        

                                5.2.7 Y-o-Y Growth Analysis, By Type                                     

                                5.2.8 Market Attractiveness Analysis, By Type                                   

                                5.2.9 Market Share Analysis, By Type                                     

                5.3 Disease       

                                5.3.1 Introduction                                           

                                5.3.2 Acute Coronary Syndrome

                                5.3.3 Myocardial Infarction                                         

                                5.3.4 Congestive Heart Failure                                   

                                5.3.5 Y-o-Y Growth Analysis, By Disease

                                5.3.6  Market Attractiveness Analysis, By Disease                                             

                                5.3.7  Market Share Analysis, By Disease                                              

                5.4 Type of Testing        

                                5.4.1 Introduction                                           

                                5.4.2 Lab                                             

                                5.4.3 Point-Of-Care Testing                                        

                                5.4.4 Y-o-Y Growth Analysis, By Type of Testing                                                

                                5.4.5  Market Attractiveness Analysis, By Type of Testing                                             

                                5.4.6  Market Share Analysis, By Type of Testing                                               

6. Geographical Analysis                     

                6.1 Introduction      

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

6.1.3.1 By Geographical Area                     

6.1.3.2 By Product                           

6.1.3.3 By Type                 

6.1.3.4 By Disease                           

6.1.3.5 By Type of Testing                            

                                6.1.4  Market Attractiveness Analysis                                     

6.1.4.1 By Geographical Area                     

6.1.4.2 By Product                           

6.1.4.3 By Type                 

6.1.4.4 By Disease                           

6.1.4.5 By Type of Testing                            

                                6.1.5  Market Share Analysis                                      

6.1.5.1 By Geographical Area                     

6.1.5.2 By Product                           

6.1.5.3 By Type                 

6.1.5.4 By Disease                           

6.1.5.5 By Type of Testing                            

                6.2 China    

                6.3 India     

                6.4 Japan   

                6.5 South Korea      

                6.6 Australia     

                6.7 Rest of APAC

7.Strategic Analysis               

                7.1 PESTLE analysis

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis     

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                

                8.1 Getinge Group 

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Medtronic plc   

                8.3 LivaNova PLC    

                8.4 XENIOS Roche Diagnostics Ltd.  

                8.5 Abbott Laboratories

                8.6 Siemens AG

                8.7 Danaher Corporation    

                8.8 Alere Inc.    

                8.9 BioMérieux SA 

                8.10 LSI Medience Corporation

9.Competitive Landscape                   

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis      

                9.3 Agreements, Collaborations, and Joint Ventures

                9.4 New Product Launches

10.Market Outlook and Investment Opportunities                 

Appendix                  

                a) List of Tables 

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of Type, Product, Disease, and Testing along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Asia Pacific Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Cardiac Marker Testing  Market By Type, From 2019-2024 ( USD Billion )
  2. Asia-Pacific Troponin I & T Market By Region, From 2019-2024 ( USD Billion )
  3. Asia-Pacific Insulin Delivery Market By Region, From 2019-2024 ( USD Billion )
  4. Asia-Pacific CK-MB Market By Region, From 2019-2024 ( USD Billion )
  5. Asia-Pacific Myoglobin Market By Region, From 2019-2024 ( USD Billion )
  6. Asia-Pacific BNP Market By Region, From 2019-2024 ( USD Billion )
  7. Asia-Pacific hsCRP Market By Region, From 2019-2024 ( USD Billion )
  8. Asia-Pacific Cardiac Marker Testing  Market By Product, From 2019-2024 ( USD Billion )
  9. Asia-Pacific Reagent Market By Region, From 2019-2024 ( USD Billion )
  10. Asia-Pacific Instrument Market By Region, From 2019-2024 ( USD Billion )
  11. Asia-Pacific Chemiluminescence Market By Region, From 2019-2024 ( USD Billion )
  12. Asia-Pacific Immunofluorescence Market By Region, From 2019-2024 ( USD Billion )
  13. Asia-Pacific Immunochromatography Market By Region, From 2019-2024 ( USD Billion )
  14. Asia-Pacific ELISA Market By Region, From 2019-2024 ( USD Billion )
  15. Asia-Pacific Cardiac Marker Testing  Market By Disease, From 2019-2024 ( USD Billion )
  16. Asia-Pacific Acute Coronary Syndrome Market By Region, From 2019-2024 ( USD Billion )
  17. Asia-Pacific Myocardial Infarction Market By Region, From 2019-2024 ( USD Billion )
  18. Asia-Pacific Congestive Heart Failure Market By Region, From 2019-2024 ( USD Billion )
  19. Asia-Pacific Cardiac Marker Testing  Market By Testing, From 2019-2024 ( USD Billion )
  20. Asia-Pacific Lab Market By Region, From 2019-2024 ( USD Billion )
  21. Asia-Pacific POC  Market By Region, From 2019-2024 ( USD Billion )
  22. Japan Cardiac Marker Testing  Market By Type, From 2019-2024 ( USD Billion )
  23. Japan Cardiac Marker Testing  Market By Product, From 2019-2024 ( USD Billion )
  24. Japan Cardiac Marker Testing  Market By Disease, From 2019-2024 ( USD Billion )
  25. Japan Cardiac Marker Testing  Market By Testing, From 2019-2024 ( USD Billion )
  26. China Cardiac Marker Testing  Market By Type, From 2019-2024 ( USD Billion )
  27. China Cardiac Marker Testing  Market By Product, From 2019-2024 ( USD Billion )
  28. China Cardiac Marker Testing  Market By Disease, From 2019-2024 ( USD Billion )
  29. China Cardiac Marker Testing  Market By Testing, From 2019-2024 ( USD Billion )
  30. India Cardiac Marker Testing  Market By Type, From 2019-2024 ( USD Billion )
  31. India Cardiac Marker Testing  Market By Product, From 2019-2024 ( USD Billion )
  32. India Cardiac Marker Testing  Market By Disease, From 2019-2024 ( USD Billion )
  33. India Cardiac Marker Testing  Market By Testing, From 2019-2024 ( USD Billion )
  34. Australia Cardiac Marker Testing  Market By Type, From 2019-2024 ( USD Billion )
  35. Australia Cardiac Marker Testing  Market By Product, From 2019-2024 ( USD Billion )
  36. Australia Cardiac Marker Testing  Market By Disease, From 2019-2024 ( USD Billion )
  37. Australia Cardiac Marker Testing  Market By Testing, From 2019-2024 ( USD Billion )
  38. South Korea Cardiac Marker Testing  Market By Type, From 2019-2024 ( USD Billion )
  39. South Korea Cardiac Marker Testing  Market By Product, From 2019-2024 ( USD Billion )
  40. South Korea Cardiac Marker Testing  Market By Disease, From 2019-2024 ( USD Billion )
  41. South Korea Cardiac Marker Testing  Market By Testing, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample